» Articles » PMID: 38758879

Malnutrition in Sickle Cell Anemia: Prevalence, Impact, and Interventions: A Review

Overview
Specialty General Medicine
Date 2024 May 17
PMID 38758879
Authors
Affiliations
Soon will be listed here.
Abstract

Sickle Cell Anemia (SCA) is a hereditary hemoglobinopathy characterized by chronic hemolytic anemia, vaso-occlusive events, and a wide range of clinical complications. Malnutrition, often an underexplored aspect of this complex condition, plays a critical role in disease management and overall patient well-being. This publication provides a comprehensive review of the prevalence, impact, and interventions related to malnutrition in individuals with SCA. A thorough literature review reveals the multifaceted challenges faced by SCA patients in maintaining adequate nutrition. The pathophysiology of SCA, involving chronic inflammation, oxidative stress, and hypermetabolism, contributes to increased nutritional requirements and altered dietary patterns. Factors such as reduced appetite, nutrient malabsorption, dietary restrictions, and socioeconomic disparities further exacerbate the risk of malnutrition. Malnutrition is a prevalent issue among individuals with SCA, affecting patients of different age groups and disease severities. Nutritional deficiencies, including vitamins, minerals, and essential nutrients, are common in this population. The impact of malnutrition on disease outcomes is significant, with associations between nutrient status and complications such as pain crises, infections, and impaired quality of life. This paper also reviews nutritional interventions aimed at addressing malnutrition in SCA patients. While dietary counseling, supplementation, and personalized nutrition plans have shown promise in improving nutritional status, challenges such as patient adherence and access to healthcare must be addressed to optimize their effectiveness.

Citing Articles

Association of phenylalanine and tyrosine metabolism with mortality and response to nutritional support among patients at nutritional risk: a secondary analysis of the randomized clinical trial EFFORT.

Buchmueller L, Wunderle C, Laager R, Bernasconi L, Neyer P, Tribolet P Front Nutr. 2024; 11:1451081.

PMID: 39600719 PMC: 11588475. DOI: 10.3389/fnut.2024.1451081.


Potassium dynamics in sickle cell anemia: clinical implications and pathophysiological insights.

Obeagu E Ann Med Surg (Lond). 2024; 86(10):6037-6045.

PMID: 39359761 PMC: 11444568. DOI: 10.1097/MS9.0000000000002551.


Telomere Dynamics in Sickle Cell Anemia: Unraveling Molecular Aging and Disease Progression.

Obeagu E, Obeagu G J Blood Med. 2024; 15:313-323.

PMID: 39081620 PMC: 11288316. DOI: 10.2147/JBM.S462758.

References
1.
Prevost R, Feugueur G, Moizan H, Keribin P, Kimakhe J, Veyssiere A . Management of patients with sickle cell disease in oral surgery. Literature review and update. J Stomatol Oral Maxillofac Surg. 2018; 119(6):493-497. DOI: 10.1016/j.jormas.2018.06.010. View

2.
Williams R, Olivi S, Li C, Storm M, Cremer L, Mackert P . Oral Glutamine Supplementation Decreases Resting Energy Expenditure in Children and Adolescents With Sickle Cell Anemia. J Pediatr Hematol Oncol. 2004; 26(10):619-625. DOI: 10.1097/01.mph.0000140651.65591.b8. View

3.
Gabrovec B, Antoniadou E, Soleymani D, Kadalska E, Carriazo A, Samaniego L . Need for comprehensive management of frailty at an individual level: European perspective from the advantage joint action on frailty. J Rehabil Med. 2020; 52(6):jrm00075. DOI: 10.2340/16501977-2687. View

4.
Khan S, Damanhouri G, Ali A, Khan S, Khan A, Bakillah A . Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional consideration. Nutr Metab (Lond). 2016; 13:50. PMC: 4977632. DOI: 10.1186/s12986-016-0109-7. View

5.
Esezobor C, Akintan P, Akinsulie A, Temiye E, Adeyemo T . Wasting and stunting are still prevalent in children with sickle cell anaemia in Lagos, Nigeria. Ital J Pediatr. 2016; 42(1):45. PMC: 4857256. DOI: 10.1186/s13052-016-0257-4. View